PatientsLikeMe : Zolmitriptan Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Taking Zolmitriptan
12 Patients currently take Zolmitriptan
4 Patients stopped taking Zolmitriptan
KatieMay Mouth/throat: none Arms: none Chest: none Legs: mild Type: Upper Motor Neuron See profile KatieMay Zomig, since Jan 03, 2005

What is Zolmitriptan? Zolmitriptan is used to treat the symptoms of migraine headache. It is in a class of medications called selective serotonin (5-HT) receptor agonists. It does not prevent migraine headaches. It comes in oral tablet form or as a nasal spray. Read more...

See more information, including instructions, precautions, side effects, and interactions.

Jump to:: Reasons Taken; Dosages; Duration; Patient Evaluations

Reasons Taken

16 patients in the community are taking or have taken Zolmitriptan.

Reason	# Patients	Percentage of patients
Other	10	62%
Headaches/ Migraines	2	12%
Headaches	2	12%
Migraines	2	12%

Dosages

Based on the patients currently taking Zolmitriptan.

0 mg none	0 none	0.16665 mg month
10	1	1

Duration

How long current patients have been taking Zolmitriptan or how long patients were taking Zolmitriptan before stopping.

Currently taking Zolmitriptan

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	1	2	5

Stopped taking Zolmitriptan

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
1	1	0	1	0	1

Why Patients Stopped Taking Zolmitriptan (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Doctor's advice	2	50%
Did not seem to work	1	25%
Personal research	1	25%
Other	1	25%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Moderate	50%	1
None	50%	1

Other

Side-effects (as an overall problem)

Severe	67%	2
Moderate	0%	0
Mild	33%	1
None	0%	0

Top reported side-effects include: Tingling in face, Chest Pain, disabled unable to walk or stand-bedriden

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 3)

mountabora

Depression: 0

Emotional: 0

Compulsion: 0

Anxiety: 0

Mania: 0

Physical: 0

External Stress: Severe

24 F

Function: High

Distress: Low

See profile
by mountabora
Oct 01, 2006

EfficacyMajor
Side-effectsMild

Headaches

See full evaluation
0 helpful marks

dbrister

Sensation: Moderate

Overall: Moderate

Cognition: moderate

Vision: moderate

Speech: moderate

Swallowing: moderate

Upper limb: moderate

Walking: moderate

See profile
by dbrister
Oct 22, 2006